Abstract
To describe a case of recurrent acute hepatitis related to the use of cetirizine, a selective histamine(1)-receptor antagonist approved for the treatment of common allergic diseases. A 26-year-old man was hospitalized with a week-long history of weakness, nausea, anorexia, and hyperchromic urine, which had developed after 6 days of therapy with oral cetirizine 10 mg/day for allergic rhinitis. Admission laboratory testing revealed evidence of acute hepatitis and seropositivity for liver-kidney microsome antibodies. Liver biopsy findings of diffuse portal tract and lobular inflammation with a prominent eosinophilic infiltrate were consistent with drug-related hepatitis. The patient was discharged after one week of treatment with tocopherol and glutathione. Three months after discharge, transaminase levels were normal. At 6 months, seropositivity for liver-kidney microsome antibodies was still present, but considerably less intense. The patient had suffered 2 previous episodes of "acute hepatitis of unknown origin," and both had occurred after cetirizine use. Use of the Naranjo probability scale indicated cetirizine as the probable cause of acute hepatitis, and the positivity for liver-kidney microsome antibodies is suggestive of ...Continue Reading
References
Nov 1, 1991·Clinical Pharmacokinetics·F E Simons, K J Simons
Oct 1, 1991·The Journal of Clinical Investigation·M P MannsE F Johnson
Aug 1, 1991·Journal of Autoimmunity·M GueguenF Alvarez
Nov 1, 1990·Drugs·D M Campoli-RichardsA Fitton
Mar 1, 1989·The Journal of Clinical Investigation·M P MannsK F Sullivan
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·U M ZangerU A Meyer
Nov 1, 1987·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J C HombergP Grippon
Aug 1, 1981·Clinical Pharmacology and Therapeutics·C A NaranjoD J Greenblatt
Dec 8, 1995·The Journal of Biological Chemistry·S W EllisG T Tucker
Aug 18, 1995·Journal of Medicinal Chemistry·A M ter LaakH Timmerman
Oct 1, 1993·Journal of Clinical Pharmacology·Y HorsmansC Harvengt
Sep 26, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F CassaniF B Bianchi
Oct 27, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M P Manns, P Obermayer-Straub
Dec 22, 1999·Chemico-biological Interactions·J M NicolasJ Roba
Aug 22, 2000·Journal of Hepatology·E BallotC Johanet
Oct 18, 2000·Journal of Clinical Gastroenterology·D G FongK D Lindor
Jul 17, 2001·Annals of Internal Medicine·M WatanabeT Kaji
Mar 22, 2002·Journal of Clinical Gastroenterology·José Luis Sánchez-LombrañaRosa María Simó Martínez
Oct 5, 2002·Clinics in Liver Disease·Zhang-Xu Liu, Neil Kaplowitz
Jan 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nanda KerkarDiego Vergani
Citations
Jan 22, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Carmen FerrajoloUNKNOWN EU-ADR consortium
Sep 30, 2008·Drug Metabolism Reviews·Young-Mi AhSang Geon Kim
Dec 15, 2010·Medicina clínica·José María Prieto de PaulaAntonio Ginés Santiago
May 22, 2009·Gastroenterología y hepatología·Santiago José Rodríguez-GómezMaría Isabel Martín-Arribas
Oct 9, 2007·Clinical Therapeutics·Ozge OnurCigdem Celikel
Sep 18, 2007·Immunology and Allergy Clinics of North America·Thomas B Nutman
Jun 14, 2016·Case Reports in Hepatology·Hafiz ArshadCharles Berkelhammer
Apr 9, 2005·Current Opinion in Gastroenterology·Susan K LazerowJames H Lewis
Jul 11, 2006·Current Opinion in Allergy and Clinical Immunology·José V Castell, Marta Castell
Sep 1, 2016·Gastroenterology Report·Adil CoskunVahit Yukselen